You are here

  • Home
  • Archive
  • Volume 65, Issue 8
  • Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis

Article info

Article menu
Download PDFPDF
Extended report
Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis

Authors

  1. Correspondence to:
    Dr D Baeten
    Clinical Immunology and Rheumatology, Academic Medical Centre University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; D.L.Baeten{at}amc.uva.nl
View Full Text

Citation

Baeten D, Houbiers J, Kruithof E, et al
Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis
Annals of the Rheumatic Diseases 2006;65:990-997.

Publication history

  • Accepted December 17, 2005
  • First published January 13, 2006.
Online issue publication 
October 25, 2017

Copyright information

Copyright 2006 by Annals of the Rheumatic Diseases